Compliance · State rules

Office-use compounding in Delaware

Closed to pharmacies and open to outsourcing facilities, in one sentence beginning "Only"

USPeptideRx EditorialLast reviewed: August 30, 2026

Delaware is the cleanest statement of this batch’s pattern anywhere in the file. Its rule has a heading that names the subject — compounded medications for office use — and answers it by naming who may do it: only an FDA-registered outsourcing facility properly licensed in Delaware may distribute compounded preparations to a practitioner for office use without a patient-specific prescription. One sentence, and it disposes of both halves. A Delaware pharmacy may not be the supplier; an outsourcing facility expressly may. That makes "Delaware prohibits office use" the wrong sentence and "Delaware routes office use to 503B" the right one.

The governing rule

Delaware’s office-use position is set by 24 Del. Admin. Code 2500 § 5.1.7.1. The text below is quoted verbatim; everything outside a quote block is our summary of it, and the two are kept visually separate on purpose.

24 Del. Admin. Code 2500 § 5.1.7.1 — the whole answer, under a heading that names the question

Compounded nonsterile or sterile preparations for human use provided by a Delaware licensed pharmacy without a patient specific prescription. Only an FDA-registered outsourcing facility properly licensed in Delaware may distribute to a practitioner for office use human compounded preparations without a patient-specific prescription.

What the rule requires in practice

Each item carries a confidence level. Verbatim rule text is high confidence; a reading of how two provisions interact, or a source that could not be re-verified, is not.

The rule addresses office use by nameHigh confidence: The subsection sits under the heading "Compounded medications for office use". That is rare: most states in this file answer the question incidentally, through a definition or a prescription requirement that happens to exclude it. Delaware wrote a provision about the thing itself, which makes it unusually safe to cite and unusually hard to misread.
The word that does the work is "Only"High confidence: The sentence is exclusive rather than prohibitive. It does not say office-use supply is forbidden; it says one type of supplier may do it. Both consequences follow from the same clause — a Delaware-licensed pharmacy is not that supplier, and a properly licensed FDA-registered outsourcing facility is.
Sterile and non-sterile are treated togetherHigh confidence: The sentence reaches "nonsterile or sterile preparations" in one breath, so there is no non-sterile concession to fall back on and no separate sterile rule to check. Whatever the preparation, the answer is the same and it turns on who is supplying it.
The permitted actor is defined by federal registrationHigh confidence: The rule stands on Delaware’s own force but its qualifying supplier is defined federally: an FDA-registered outsourcing facility that also holds a Delaware licence. Both are required. State permission still does not create a federal exemption — 21 U.S.C. § 353a conditions the federal exemptions on a patient-specific prescription, and the two questions stay independent.
The veterinary limb is next door and is cappedMedium confidence: The following subsection deals with compounded preparations for animals and carries a quantity limit of its own. The human limb quoted above carries no numeric cap, because it does not need one: it disposes of the question by naming the supplier instead.
Last change, and a warning about how to read this rule onlineHigh confidence: Delaware’s pharmacy regulation section has been amended repeatedly, most recently with effect from 1 January 2026. If you go looking for the text yourself, be careful: the state’s regulations website is a single-page application that answers every address — including ones ending in .pdf — with the same shell page and no regulation text at all. It returns a success status and tens of kilobytes while containing none of the rule. This page cites the registrar’s actual document file instead.

Delaware at a glance

Delaware office-use compounding summary, reviewed 2026-08-30
Human office use	Only an FDA-registered outsourcing facility licensed in Delaware may supply it
Sterile preparations	No split — the sentence reaches nonsterile and sterile together
Quantity cap	None on the human limb; the veterinary limb is capped
Mandatory label legend	None on the human limb
Board reporting	None for office use
Last change	Section last amended effective 1 January 2026
Governing rule	24 Del. Admin. Code 2500 § 5.1.7.1

Receiving 503B office stock in Delaware

Delaware uses the literal term for the credential, so its law is searchable, and the answer for a practice here is unusually clear: the supplier must be an outsourcing facility holding a Delaware licence. The wrinkle is that pharmacy licensing and controlled-substance registration live in two different cabinet departments.

Everything above this heading answers the supply question: may a state-licensed 503A pharmacy ship non-patient-specific stock? This section answers the other half. Registration with FDA under section 503B is a federal exemption from federal law and preempts no state licensing scheme, so it is never the whole answer on its own — a state credential is the norm rather than the exception, it is not always issued by the board of pharmacy, and in some states the category you would search for does not exist. What Delaware asks for is set out below, including where we could not establish it.

What the 503B must hold to ship inHigh confidence: Two things at once, and the rule says so: registration with the FDA as an outsourcing facility, and a Delaware licence. Pharmacy licensing runs through the Division of Professional Regulation within the Department of State.
Does your practice need a permit?Low confidence: Not established in detail for this page. The rule places the qualifying condition on the supplier rather than on the receiving practice, so the question a Delaware practice faces first is whether its supplier holds both credentials.
Administer vs dispenseMedium confidence: The rule is about distribution to a practitioner for office use without a patient-specific prescription. It settles who may make that distribution rather than what the practitioner may then do, so the administer-versus-dispense question is not the one this provision answers.
Scheduled (controlled) stockMedium confidence: Delaware runs controlled-substance registration through the Department of Health and Social Services — a different cabinet department from the one that licenses pharmacies. Anyone searching the professional-regulation material for controlled-substance requirements will not find them there.

How to check a facility’s credential before you order is set out in how to place an office-use order.

The federal layer still applies

Whatever Delaware law allows, federal law applies on top of it and is not satisfied by state permission. 21 U.S.C. § 353a conditions the federal compounding exemptions on a drug being compounded for an identified individual patient on receipt of a valid prescription order. A state rule cannot create a federal safe harbour, and several state rules say so in their own text. The separate federal pathway for non-patient-specific office stock is the 503B outsourcing facility — the differences are set out in 503A vs 503B.

For how Delaware compares with the other states reviewed, see the state-by-state comparison.

What this page does not establish

One practical warning if you check Delaware yourself, because it will waste your time otherwise: the state’s regulations website answers every address on the host with the same application shell — a success status, tens of kilobytes, and not one word of regulation text. That includes addresses ending in .pdf. Neither the status code nor the page size tells you anything; only reading the served text does. This page cites the registrar’s document file, which does contain the rule.
The receiving-side permit question for a Delaware practice was not established and is left blank here rather than inferred from the supply-side rule.
Whether Delaware has a percentage-based wholesale exemption of the kind several other states use was not checked for this page.
We searched no case law, attorney-general opinions or disciplinary orders for this state, and search engines were unavailable when it was researched. Read nothing into that silence — it means we have not looked, not that nothing is there.

Sources

Primary sources, fetched directly from the issuing body. No secondary summaries.